THERAPY WITH ANTIBODY-COATED IMMUNE AND HYPERIMMUNE PERITONEAL CELLS IN A MURINE LYMPHOMA SYSTEMDULLENS HFJ; DE WEGER RA; WOUTERSEN RA et al.1975; J. NATION. CANCER INST.; U.S.A.; DA. 1975; VOL. 54; NO 1; PP. 77-82; BIBL. 29REF.Article

SEPARATION OF A TUMOUR SPECIFIC TRANSPLANTATION-TYPE ANTIGEN FROM THE ASCITIC FLUID OF MICE BEARING A SYNGENEIC LYMPHOMA = SEPARATION D'UN ANTIGENE DE TYPE "ANTIGENE DE TRANSPLANTATION" SPECIFIQUE DE LA TUMEUR A PARTIR DU LIQUIDE ASCITIQUE DES SOURIS PORTANT DES LYMPHOMES SYNGENIQUESWOLF A; STEELE KA.1975; BRIT. J. CANCER; G.B.; DA. 1975; VOL. 31; NO 6; PP. 684-688; BIBL. 6 REF.Article

MACROPHAGES IN SOLID TUMORS. I. IMMUNOLOGICALLY SPECIFIC EFFECTOR CELLSVAN LOVEREN H; DEN OTTER W.1974; J. NATION. CANCER INST.; U.S.A.; DA. 1974; VOL. 53; NO 4; PP. 1057-1060; BIBL. 11REF.Article

THERAPY WITH ALLOGENEIC IMMUNE PERITONEAL CELLSDULLENS HFJ; OTTER WD.1974; CANCER RES.; U.S.A.; DA. 1974; VOL. 34; NO 7; PP. 1726-1730; BIBL. 23REF.Article

THE DESTRUCTION OF ALLOGENEIC TUMOR CELLS BY ANTIBODY AND ADHERENT CELLS FROM PERITONEAL CAVITIES OF MICEJOLLEY GM; BOYLE MDP; ORMEROD MG et al.1976; CELL. IMMUNOL.; U.S.A.; DA. 1976; VOL. 22; NO 2; PP. 262-270; BIBL. 45 REF.Article

ERADICATION OF TUMOUR CELLS BY SUCCESSIVE INJECTIONS OF ALLOGENEIC IMMUNE AND HYPERIMMUNE PERITONEAL CELLS IN A MURINE LYMPHOMA SYSTEMDULLENS HFJ; WOUTERSEN RA; DE WEGER RA et al.1974; EUROP. J. CANCER; G.B.; DA. 1974; VOL. 10; NO 11; PP. 701-706; BIBL. 19REF.Article

DESTRUCTION OF MURINE LYMPHOMA CELLS BY ALLOGENEIC PERITONEAL MACROPHAGES IN VITRO: INFLUENCE OF ANTISERUM = DESTRUCTION DES CELLULES DE LYMPHOME MURIN PAR LES MACROPHAGES ALLOGENIQUES PERITONEAUX IN VITRO: INFLUENCE DES IMMUNSERUMSDINGEMANS KP; PELS E; VAN DONGEN G et al.1983; JOURNAL OF THE NATIONAL CANCER INSTITUTE; ISSN 0027-8874; USA; DA. 1983; VOL. 70; NO 1; PP. 181-189; ABS. ENG; BIBL. 24 REF.; GRAPH, FIGArticle

MACROPHAGE TUMOR CELLS CAN HELP TO CURE MURINE LYMPHOMAVAN LOVEREN H; DE GROOT JW; DEN OTTER W et al.1981; PROC. SOC. EXP. BIOL. MED.; ISSN 0037-9727; USA; DA. 1981; VOL. 167; NO 2; PP. 207-211; BIBL. 17 REF.Article

IN VITRO ACTIVATION OF ARMED MACROPHAGES AND THE THERAPEUTIC APPLICATION IN MICEVAN LOVEREN H; OTTER WD.1974; J. NATION. CANCER INST.; U.S.A.; DA. 1974; VOL. 52; NO 6; PP. 1917-1918; BIBL. 9REF.Article

THE ROLE OF A CYTOPHILIC FACTOR FROM CHALLENGED IMMUNE PERITONEAL LYMPHOCYTES IN SPECIFIC MACROPHAGE CYTOTOXICITYPELS E; DEN OTTER W.1974; CANCER RES.; U.S.A.; DA. 1974; VOL. 34; NO 11; PP. 3089-3094; BIBL. 21 REF.Article

ESTIMATION IN SERA BY RADIOIMMUNOASSAY OF SPECIFIC MEMBRANE ANTIGEN ASSOCIATED WITH A MURINE LYMPHOMAWOLF A; STEELE KA; ALEXANDER P et al.1976; BRIT. J. CANCER; G.B.; DA. 1976; VOL. 33; NO 2; PP. 144-153; BIBL. 10 REF.Article

THE DESTRUCTION OF ALLOGENEIC TUMOUR CELLS BY PERITONEAL MACROPHAGES FROM IMMUNE MICE: PURIFICATION OF LYTIC EFFECTOR CELLS = LA DESTRUCTION DES CELLULES TUMORALES ALLOGENIQUES PAR LES MACROPHAGES PERITONEAUX DES SOURIS IMMUNES: PURIFICATION DES CELLULES EFFECTUEES LYTIQUESBOYLE MDP; ORMEROD MG.1975; CELL. IMMUNOL.; U.S.A.; DA. 1975; VOL. 17; NO 1; PP. 247-258; BIBL. 19 REF.Article

Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipientsDEN OTTER, W; DE GROOT, J. W; DULLENS, H. F. J et al.Cancer immunology and immunotherapy. 1983, Vol 16, Num 2, pp 72-76, issn 0340-7004Article

FURTHER EVIDENCE FOR DEREPRESSION OF H-2 AND IA-LIKE SPECIFITIES OF FOREIGN HAPLOTYPES IN MOUSE TUMOUR CELL LINES.GARRIDO F; FESTENSTEIN H.1976; NATURE; G.B.; DA. 1976; VOL. 261; NO 5562; PP. 705-707; BIBL. 21 REF.Article

COMPARISON OF VARIOUS FORMS OF THERAPY IN TWO DIFFERENT MOUSE TUMOR SYSTEMSDULLENS HFJ; VENNEGOOR C; DE WEGER RA et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 1; PP. 99-109; BIBL. 40 REF.Article

DIFFERENCES IN THE EXPRESSION OF HISTOCOMPATIBILITY ANTIGENS ON MOUSE LYMPHOCYTES AND TUMOR CELLS: IMMUNOCHEMICAL STUDIESROBINSON PJ; SCHIRRMACHER V.1979; EUROP. J. IMMUNOL.; DEU; DA. 1979; VOL. 9; NO 1; PP. 61-66; BIBL. 16 REF.Article

A SEROLOGICALLY DETECTED TUMOUR-SPECIFIC MEMBRANE ANTIGEN OF MURINE LYMPHOMAS WHICH IS NOT THE TARGET FOR SYNGENEIC GRAFT REJECTIONDAVEY GC; CURRIE GA; ALEXANDER P et al.1979; BRIT. J. CANCER; GBR; DA. 1979; VOL. 40; NO 1; PP. 168-170; BIBL. 6 REF.Article

DESTRUCTION OF MURINE LYMPHOMA CELLS BY ALLOGENEIC IMMUNE PERITONEAL MACROPHAGES IN VITRO: AN ULTRASTRUCTURE STUDYDINGEMANS KP; PELS E; DEN OTTER W et al.1981; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1981; VOL. 66; NO 1; PP. 67-79; BIBL. 41 REF.Article

SPECIFIC AND NONSPECIFIC ANTITUMOR IMMUNITY. III. SPECIFIC T LYMPHOCYTE-MEDIATED CYTOLYSIS OF P815 MASTOCYTOMA AND SL2 LYMPHOMA BY DRAINING LYMPH NODE CELLS FROM SYNGENIC TUMOR-BEARING DBA/2J MICE.GERMAIN RN; WILLIAMS RM; BENACERRAF B et al.1976; AMER. J. PATHOL.; U.S.A.; DA. 1976; VOL. 85; NO 3; PP. 661-673; BIBL. 44 REF.Article

CHARACTERIZATION OF ANTIGENS ON MURINE TUMOR CELLS REACTING WITH ALLOANTISERA AGAINST FOREIGN H-2 SPECIFICITIES: ANALYSIS BY ABSORPTION WITH PURIFIED MURINE LEUKEMIA VIRUS AND NORMAL LYMPHOID CELLS OF DIFFERENT H-2 HAPLOTYPESSCHIRRMACHER V; MARXEN I; ROBINSON P et al.1978; Z. IMMUN.-FORSCH.; DEU; DA. 1978; VOL. 155; NO 2; PP. 155-168; BIBL. 31 REF.Article

THE PRODUCTION OF ANTIBODIES TO ALLOGENEIC TUMOR CELLS BY MOUSE SPLEEN IN VITRO.JOLLEY GM.1976; CELL. IMMUNOL.; U.S.A.; DA. 1976; VOL. 25; NO 1; PP. 52-59; BIBL. 23 REF.Article

Characterization of tumor progression from threshold tumor inocula: evidence for natural resistanceBROWN, G. W; CHOW, D. A.International journal of cancer. 1985, Vol 35, Num 3, pp 385-393, issn 0020-7136Article

Immune reactivity in SL2 lymphoma-bearing mice compared with SL2-immunized miceDE WEGER, R. A; WILBRINK, B; MOBERTS, R. M. P et al.Cancer immunology and immunotherapy. 1987, Vol 24, Num 1, pp 25-36, issn 0340-7004Article

Site-related differences in the localization of the monoclonal antibody OX7 in SL2 and SL1 lymphomasSANDS, H; JONES, P. L; NEACY, W. P et al.Cancer immunology and immunotherapy. 1986, Vol 22, Num 3, pp 169-175, issn 0340-7004Article

Immunotherapy of mice with a large burden of disseminated lymphoma with low-dose interleukin 2MAAS, R. A; DULLENS, H. F. J; DE JONG, W. H et al.Cancer research (Baltimore). 1989, Vol 49, Num 24, pp 7037-7040, issn 0008-5472, part 1Article